Exit news: OrthoSensor and its knee surgery sensor technology acquired by Stryker

OrthoSensor, a Dania Beach-based medical technology company that develops sensor-assisted orthopedic technology for the knee, was built by a group of former executives at medical robotics company Mako Surgical. Mako Surgical was sold to Michigan-based medical device company Stryker in 2013. This week. Stryker announced it acquired OrthoSensor.
The acquisition allows Stryker to move into the digitalization of musculoskeletal care and sensor technology for total joint replacement, OrthoSensor’s key focus. Terms of the deal were not released.
OrthoSensor, led by CEO Ivan Delevic, is an example of another successful medtech company built in South Florida, tweeted Maurice R. Ferre, who led Mako as CEO through its IPO and then its $1.6 billion sale to Stryker. He’s now running Insightec from South Florida. “I love the fact that Mako employees are company building,” he said, and there is more to come. “We have an ecosystem building the next generation of tech unicorns.”
In addition to OrthoSensor, Mako’s talent went on to spawn South Florida companies such as Magic Leap, Neocis, DermaSensor and of course Insightec.
OrthoSensor, founded in 2007, is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement. With technologies spanning continuum of care, the acquisition of OrthoSensor allows Stryker to empower surgeons with comprehensive data-driven solutions.
“Smart devices and implants will play a big role in orthopaedics and we are excited for OrthoSensor to join Stryker as we continue to innovate and advance smart sensor technologies, including intraoperative sensors, wearables and smart implants across our joint replacement business,” said Spencer Stiles, Stryker’s Group President, Orthopaedics and Spine. “Patient recovery will become more active as real-time measurement on key performance insights drive improved outcomes and patient satisfaction.”
Over the years, OrthoSensor raised over $100 million in venture capital, according to Crunchbase.
Follow @ndahlberg on Twitter and email her at [email protected]

Nancy Dahlberg